Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

Journal of the American College of Cardiology

Volumn 48, Issue 12, 2006, Pages 2546-2552

  Hoeper, Marius M ^a   Lee, Stephen H ^b   Voswinckel, Robert ^c   Palazzini, Massimiliano ^d   Jais, Xavier ^e   Marinelli, Alessandro ^d   Barst, Robyn J ^f   Ghofrani, Hossein A ^c   Jing, Zhi Cheng ^e   Opitz, Christian ^g   Seyfarth, Hans Juergen ^h   Halank, Michael ⁱ   McLaughlin, Vallerie ^j   Oudiz, Ronald J ^k   Ewert, Ralf ^l   Wilkens, Heinrike ^m   Kluge, Stefan ⁿ   Bremer, Hinrich Cordt ^o   Baroke, Eva ^a   Rubin, Lewis J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UCSD MEDICAL CENTER   (United States)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

^g DRK KLINIKEN BERLIN WESTEND   (Germany)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k HARBOR UCLA MEDICAL CENTER   (United States)

^l UNIVERSITY OF GREIFSWALD   (Germany)

^m SAARLAND UNIVERSITY   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^o UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; FEMALE; HEART ARRHYTHMIA; HEART CATHETER; HEART CATHETERIZATION; HEMATOMA; HUMAN; HYPOTENSION; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; REST; RETROSPECTIVE STUDY; RISK ASSESSMENT; VASCULAR ACCESS;

AGED; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; INTRAOPERATIVE COMPLICATIONS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK;

EID: 33845343982     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.07.061     Document Type: Article

References (39)

1. Barst R.J., McGoon M., Torbicki A., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 40S-47S
2. Galie N., Torbicki A., Barst R., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25 (2004) 2243-2278
3. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
4. Channick R.N., Simonneau G., Sitbon O., et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358 (2001) 1119-1123
5. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
6. Galie N., Badesch D., Oudiz R., et al. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol 46 (2005) 529-535
7. Galie N., Humbert M., Vachiery J.L., et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 39 (2002) 1496-1502
8. Barst R.J., Langleben D., Frost A., et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447
9. Simonneau G., Barst R.J., Galie N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 (2002) 800-804
10. Hoeper M.M., Oudiz R.J., Peacock A., et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43 (2004) 48S-55S
11. Caldini P., Gensini G.G., and Hoffman M.S. Primary pulmonary hypertension with death during right heart catheterization. A case report and a survey of reported fatalities. Am J Cardiol 4 (1959) 519-527
12. Snider G.L. Primary pulmonary hypertension: a fatality during pulmonary angiography. Clinical conference from Boston University School of Medicine. Chest 64 (1973) 628-635
13. Fuster V., Steele P.M., Edwards W.D., Gersh B.J., McGoon M.D., and Frye R.L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70 (1984) 580-587
14. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 (1987) 216-223
15. McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 14S-34S
16. Sitbon O., Humbert M., Jais X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111 (2005) 3105-3111
17. Fedullo P.F., Auger W.R., Kerr K.M., and Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 345 (2001) 1465-1472
18. Klepetko W., Mayer E., Sandoval J., et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 73S-80S
19. Moser K.M., Auger W.R., and Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 81 (1990) 1735-1743
20. Watson H. Severe pulmonary hypertensive episodes following angiocardiography with sodium metrizoate. Lancet 171 (1964) 732-733
21. Mills S.R., Jackson D.C., Older R.A., Heaston D.K., and Moore A.V. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series. Radiology 136 (1980) 295-299
22. Perlmutt L.M., Braun S.D., Newman G.E., Oke E.J., and Dunnick N.R. Pulmonary arteriography in the high-risk patient. Radiology 162 (1987) 187-189
23. Nicod P., Peterson K., Levine M., et al. Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med 107 (1987) 565-568
24. Pitton M.B., Duber C., Mayer E., and Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. Circulation 94 (1996) 2485-2491
25. Hudson E.R., Smith T.P., McDermott V.G., et al. Pulmonary angiography performed with iopamidol: complications in 1,434 patients. Radiology 198 (1996) 61-65
26. Hofmann L.V., Lee D.S., Gupta A., et al. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience. AJR Am J Roentgenol 183 (2004) 779-786
27. Hoeper M.M., Galie N., Murali S., et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 165 (2002) 341-344
28. Scanlon P.J., Faxon D.P., Audet A.M., et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33 (1999) 1756-1824
29. Harvey S., Harrison D.A., Singer M., et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 366 (2005) 472-477
30. Olschewski H., Walmrath D., Schermuly R., Ghofrani A., Grimminger F., and Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 124 (1996) 820-824
31. Hoeper M.M., Olschewski H., Ghofrani H.A., et al., German PPH Study Group. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. J Am Coll Cardiol 35 (2000) 176-182
32. Peck W.W., Slutsky R.A., Hackney D.B., Mancini G.B., and Higgins C.B. Effects of contrast media on pulmonary hemodynamics: comparison of ionic and non-ionic agents. Radiology 149 (1983) 371-374
33. Smith T.P., Lee V.S., Hudson E.R., et al. Prospective evaluation of pulmonary artery pressures during pulmonary angiography performed with low-osmolar nonionic contrast media. J Vasc Interv Radiol 7 (1996) 207-212
34. Pitton M.B., Kemmerich G., Herber S., Mayer E., Thelen M., and Duber C. Hemodynamic effects of monomeric nonionic contrast media in pulmonary angiography in chronic thromboembolic pulmonary hypertension. AJR Am J Roentgenol 187 (2006) 128-134
35. Kaiser C.A., Hugli R.W., Haegeli L.M., and Pfisterer M.E. Selective embolization of a pulmonary artery rupture caused by a Cournand catheter. Catheter Cardiovasc Interv 61 (2004) 317-319
36. Larson B.J., Zumberg M.S., and Kitchens C.S. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 127 (2005) 922-927
37. Shah M.R., Hasselblad V., Stevenson L.W., et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294 (2005) 1664-1670
38. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633
39. Merrer J., De Jonghe B., Golliot F., et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286 (2001) 700-707